The GLP-1 agonist exendin-4 attenuates self-administration of sweetened fat on fixed and progressive ratio schedules of reinforcement in rats
at 80C, possibly longer, though some gradual degradation (like deamidation or oxidation) may still occur over time
Just as important: we can pair medication with post-bariatric nutrition coaching, protein targets, and habit strategies tailored to your anatomy and needs
Kindel TL, Wang AY, Wadhwa A, Schulman AR, Sharaiha RZ, Kroh M, et al
not through restriction, but through science-backed wellness injections that nourish your biology